Immune landscape and prognostic immune-related signature in KRAS-mutated lung adenocarcinoma

The heterogeneity of lung adenocarcinoma (LUAD) indicated that target therapies and immunotherapies may not be effective in all patients. The exploration of the feature of the immune landscape of different gene mutations may provide novel perspectives. In this study, we obtained LUAD samples from Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Xinyi, Xia, Zhenqi, Guo, Yong, Li, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2023
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10292897/
https://www.ncbi.nlm.nih.gov/pubmed/37279937
http://dx.doi.org/10.18632/aging.204770

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10292897/
https://www.ncbi.nlm.nih.gov/pubmed/37279937
http://dx.doi.org/10.18632/aging.204770

Ejemplares similares